AP2007003929A0 - A purified arabinogalactan-protein (agp) composition - Google Patents
A purified arabinogalactan-protein (agp) compositionInfo
- Publication number
- AP2007003929A0 AP2007003929A0 AP2007003929A AP2007003929A AP2007003929A0 AP 2007003929 A0 AP2007003929 A0 AP 2007003929A0 AP 2007003929 A AP2007003929 A AP 2007003929A AP 2007003929 A AP2007003929 A AP 2007003929A AP 2007003929 A0 AP2007003929 A0 AP 2007003929A0
- Authority
- AP
- ARIPO
- Prior art keywords
- agp
- protein
- composition
- purified arabinogalactan
- arabinogalactan
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/931,814 US7601368B2 (en) | 2004-09-01 | 2004-09-01 | Purified Arabinogalactan-Protein (AGP) composition useful in the treatment psoriasis and other disorders |
PCT/IN2005/000132 WO2006025068A1 (en) | 2004-09-01 | 2005-04-26 | A purified arabinogalactan-protein (agp) composition |
Publications (1)
Publication Number | Publication Date |
---|---|
AP2007003929A0 true AP2007003929A0 (en) | 2007-02-28 |
Family
ID=35943518
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AP2007003929A AP2007003929A0 (en) | 2004-09-01 | 2005-04-26 | A purified arabinogalactan-protein (agp) composition |
Country Status (19)
Country | Link |
---|---|
US (4) | US7601368B2 (de) |
EP (1) | EP1789439B1 (de) |
JP (1) | JP2008511613A (de) |
KR (1) | KR20070059062A (de) |
CN (1) | CN101044161A (de) |
AP (1) | AP2007003929A0 (de) |
AT (1) | ATE452142T1 (de) |
AU (1) | AU2005278780A1 (de) |
BR (1) | BRPI0514347A (de) |
CA (1) | CA2577134A1 (de) |
DE (1) | DE602005018375D1 (de) |
EA (1) | EA012208B1 (de) |
IL (1) | IL181230A0 (de) |
MX (1) | MX2007002428A (de) |
NO (1) | NO20071120L (de) |
TN (1) | TNSN07079A1 (de) |
UA (1) | UA86986C2 (de) |
WO (1) | WO2006025068A1 (de) |
ZA (1) | ZA200701311B (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1964570T3 (da) | 2007-03-02 | 2012-12-17 | Protectimmun Gmbh | Farmaceutisk sammensætning til beskyttelse mod allergier og inflammatoriske sygdomme |
FR2938192B1 (fr) | 2008-11-07 | 2012-08-24 | Expanscience Lab | Nouvel actif anti-vergetures et compositions le comprenant |
US20120128597A1 (en) * | 2008-08-16 | 2012-05-24 | Forschungszentrum Borstel | Composition for prevention and treatment of allergic and/or inflammatory diseases |
CA2797236C (en) | 2010-05-05 | 2017-10-17 | Comvita New Zealand Limited | Immunostimulatory compositions comprising a honey isolate and uses thereof |
FR2975004B1 (fr) * | 2011-05-13 | 2013-06-28 | Expanscience Lab | Nouvel actif anti-rougeurs et compositions cosmetiques le comprenant |
ITMI20112216A1 (it) | 2011-12-05 | 2013-06-06 | Fond Salvatore Maugeri Clinic A Del Lavoro E | Composizione comprendente un estratto di chelidonium majus e copaiba e il suo impiego per il trattamento di disfunzioni cutanee |
WO2014190398A1 (en) * | 2013-05-31 | 2014-12-04 | The University Of Melbourne | Inhibition of amyloid fibril formation |
EP3176175B1 (de) | 2015-12-01 | 2020-07-01 | Ruhr-Universität Bochum | Verfahren zur synthetischen herstellung von arabinogalactanverbindungen, die abgeleitet sind von pflanzen und verwendung der verbindungen zur prophylaxe von allergischen reaktionen |
US11179407B2 (en) | 2015-12-01 | 2021-11-23 | Forschungszentrum Borstel Leibniz-Zentrum Für Medizin Und Biowissenshaften | Method for synthetically producing arabinogalactan compounds derived from plants and uses of said compounds for the prophylaxis of allergic reactions |
EP3415586B1 (de) | 2016-02-12 | 2022-11-30 | Laimu Corporation | Wundbehandlungsmittel und verfahren zur herstellung davon |
JP6230638B2 (ja) * | 2016-02-12 | 2017-11-15 | 株式会社らいむ | 神経伸長促進剤、内服剤、培地用添加剤、細胞希釈液用添加剤、培地および細胞希釈液 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4818533A (en) * | 1985-07-09 | 1989-04-04 | Vipont Pharmaceutical, Inc. | Production of high purity alkaloids |
US5494671A (en) * | 1990-08-27 | 1996-02-27 | The United States Of America As Represented By The Department Of Health And Human Services | C-terminally truncated dengue and Japanese encephalitis virus envelope proteins |
JP3177642B2 (ja) * | 1991-09-10 | 2001-06-18 | ライオン株式会社 | 抗男性ホルモン剤 |
CN1179979C (zh) | 1999-06-30 | 2004-12-15 | 法蒙金希公司 | 造血的阿拉伯半乳聚糖组合物 |
CA2471490A1 (en) * | 2002-01-10 | 2003-07-17 | Lupin Limited | Herbal composition for treating various disorders including psoriasis, a process for preparation thereof and method for treatment of such disorders |
-
2004
- 2004-09-01 US US10/931,814 patent/US7601368B2/en not_active Expired - Fee Related
-
2005
- 2005-04-26 DE DE602005018375T patent/DE602005018375D1/de not_active Expired - Fee Related
- 2005-04-26 EP EP05775653A patent/EP1789439B1/de active Active
- 2005-04-26 AU AU2005278780A patent/AU2005278780A1/en not_active Abandoned
- 2005-04-26 JP JP2007529142A patent/JP2008511613A/ja active Pending
- 2005-04-26 BR BRPI0514347-0A patent/BRPI0514347A/pt not_active IP Right Cessation
- 2005-04-26 EA EA200700532A patent/EA012208B1/ru not_active IP Right Cessation
- 2005-04-26 MX MX2007002428A patent/MX2007002428A/es unknown
- 2005-04-26 AT AT05775653T patent/ATE452142T1/de not_active IP Right Cessation
- 2005-04-26 UA UAA200701654A patent/UA86986C2/ru unknown
- 2005-04-26 KR KR1020077003989A patent/KR20070059062A/ko not_active Application Discontinuation
- 2005-04-26 WO PCT/IN2005/000132 patent/WO2006025068A1/en active Application Filing
- 2005-04-26 CA CA002577134A patent/CA2577134A1/en not_active Abandoned
- 2005-04-26 CN CNA2005800355154A patent/CN101044161A/zh active Pending
- 2005-04-26 AP AP2007003929A patent/AP2007003929A0/xx unknown
-
2007
- 2007-02-08 IL IL181230A patent/IL181230A0/en unknown
- 2007-02-14 ZA ZA200701311A patent/ZA200701311B/xx unknown
- 2007-02-27 NO NO20071120A patent/NO20071120L/no not_active Application Discontinuation
- 2007-02-28 TN TNP2007000079A patent/TNSN07079A1/en unknown
-
2009
- 2009-07-02 US US12/496,924 patent/US20090264341A1/en not_active Abandoned
- 2009-07-02 US US12/497,217 patent/US20100330650A1/en not_active Abandoned
- 2009-07-02 US US12/497,148 patent/US20090270330A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20060045930A1 (en) | 2006-03-02 |
US20090270330A1 (en) | 2009-10-29 |
JP2008511613A (ja) | 2008-04-17 |
BRPI0514347A (pt) | 2008-06-10 |
MX2007002428A (es) | 2007-05-11 |
TNSN07079A1 (en) | 2008-06-02 |
ZA200701311B (en) | 2009-08-26 |
US20100330650A1 (en) | 2010-12-30 |
CA2577134A1 (en) | 2006-03-09 |
WO2006025068A8 (en) | 2006-04-20 |
NO20071120L (no) | 2007-05-14 |
ATE452142T1 (de) | 2010-01-15 |
KR20070059062A (ko) | 2007-06-11 |
EA200700532A1 (ru) | 2007-08-31 |
US7601368B2 (en) | 2009-10-13 |
DE602005018375D1 (de) | 2010-01-28 |
EP1789439B1 (de) | 2009-12-16 |
WO2006025068A1 (en) | 2006-03-09 |
UA86986C2 (ru) | 2009-06-10 |
IL181230A0 (en) | 2007-07-04 |
AU2005278780A1 (en) | 2006-03-09 |
EP1789439A1 (de) | 2007-05-30 |
EA012208B1 (ru) | 2009-08-28 |
US20090264341A1 (en) | 2009-10-22 |
CN101044161A (zh) | 2007-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200701311B (en) | A purified arabinogalactan-protein (AGP) composition | |
IL229521A0 (en) | A new preparation | |
EP1752496A4 (de) | Härtbare zusammensetzung | |
EP1818368A4 (de) | Härtbare zusammensetzung | |
EP1816168A4 (de) | Härtbare zusammensetzung | |
TWI340128B (en) | A glass composition | |
IL185901A0 (en) | Novel composition | |
EP1832626A4 (de) | Härtbare zusammensetzung | |
EP1923431A4 (de) | Härtbare zusammensetzung | |
EP1967540A4 (de) | Härtbare zusammensetzung | |
PL1913075T3 (pl) | Mieszanki kauczukowe zawierające ulepszone środki klejące | |
EP1939257A4 (de) | Härtbare zusammensetzung | |
EP1882713A4 (de) | Härtbare zusammensetzung | |
EP1754754A4 (de) | Härtbare zusammensetzung | |
EP1731549A4 (de) | Härtbare zusammensetzung | |
EP1715002A4 (de) | Härtbare zusammensetzung | |
EP1930376A4 (de) | Härtbare zusammensetzung | |
EP1731573A4 (de) | Härtbare zusammensetzung | |
EP1666536A4 (de) | Härtbare zusammensetzung | |
EP1810994A4 (de) | Härtbare zusammensetzung | |
EP1970411A4 (de) | Härtbare zusammensetzung | |
EP1810995A4 (de) | Härtbare zusammensetzung | |
EP1810996A4 (de) | Härtbare zusammensetzung | |
EP1808223A4 (de) | Lösungsmittelzusammensetzung | |
GB0525592D0 (en) | A composition |